Bavituximab Activates CD8+TILs in a 3D Ex Vivo System of Lung Cancer Patients Derived Tumors With Negative PD-L1 Expression

被引：0
|
作者：
Altiok, Soner [1 ]
Valera, Melanie Mediavilla [1 ]
Kreahling, Jenny [1 ]
Kallinteris, Nikoletta L. [2 ]
Noyes, David [3 ]
Razabdouski, Tiffany N. [3 ]
Shan, Joseph [2 ]
Hutchins, Jeff [2 ]
Menander, Kerstin [2 ]
Antonia, Scott J. [3 ]
机构：
[1] Nilogen Oncosyst, Tampa, FL USA
[2] Peregrine Pharmaceut, Clin, Tustin, CA USA
[3] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Tumor microenvironment immunomodulation; 3D tumor microspheres; Chimeric monoclonal antibody-targeted therapy; Cytokine and immne function genes profiling-TILs activation;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI14.07
引用
收藏
页码：S312 / S313
页数：2
相关论文
共 50 条
  • [41] Clinical relevance of PD-L1 expression and CD8+T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer
    Liu, Si-yang
    Dong, Zhong-yi
    Wu, Si-pei
    Xie, Zhi
    Yan, Li-xu
    Li, Yu-fa
    Yan, Hong-hong
    Su, Jian
    Yang, Jin-Ji
    Zhou, Qing
    Zhong, Wen-Zhao
    Tu, Hai-Yan
    Yang, Xue-Ning
    Zhang, Xu-Chao
    Wu, Yi-Long
    LUNG CANCER, 2018, 125 : 86 - 92
  • [42] Prognostic Relevance of CD4+, CD8+ and FOXP3+ TILs in Oral Squamous Cell Carcinoma and Correlations with PD-L1 and Cancer Stem Cell Markers
    Lequerica-Fernandez, Paloma
    Suarez-Canto, Julian
    Rodriguez-Santamarta, Tania
    Rodrigo, Juan Pablo
    Suarez-Sanchez, Faustino Julian
    Blanco-Lorenzo, Veronica
    Dominguez-Iglesias, Francisco
    Garcia-Pedrero, Juana Maria
    de Vicente, Juan Carlos
    BIOMEDICINES, 2021, 9 (06)
  • [43] Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer
    Shimada, Yoshihisa
    Matsubayashi, Jun
    Kudo, Yujin
    Maehara, Sachio
    Takeuchi, Susumu
    Hagiwara, Masaru
    Kakihana, Masatoshi
    Ohira, Tatsuo
    Nagao, Toshitaka
    Ikeda, Norihiko
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer
    Yoshihisa Shimada
    Jun Matsubayashi
    Yujin Kudo
    Sachio Maehara
    Susumu Takeuchi
    Masaru Hagiwara
    Masatoshi Kakihana
    Tatsuo Ohira
    Toshitaka Nagao
    Norihiko Ikeda
    Scientific Reports, 11
  • [45] Clinical significance of CD8 and programmed death-ligand 1 (PD-L1) expression in patients with resectable non-small cell lung cancer.
    Kim, Hye Ree
    Song, Haa-Na
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer
    Munari, Enrico
    Marconi, Marcella
    Querzoli, Giulia
    Lunardi, Gianluigi
    Bertoglio, Pietro
    Ciompi, Francesco
    Tosadori, Alice
    Eccher, Albino
    Tumino, Nicola
    Quatrini, Linda
    Vacca, Paola
    Rossi, Giulio
    Cavazza, Alberto
    Martignoni, Guido
    Brunelli, Matteo
    Netto, George J.
    Moretta, Lorenzo
    Zamboni, Giuseppe
    Bogina, Giuseppe
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [47] High expression ITGA2 affects the expression of MET, PD-L1, CD4 and CD8 with the immune microenvironment in pancreatic cancer patients
    Jin, Liquan
    Duan, Yaoqiang
    Li, Xiaoxi
    Li, Zhenqi
    Hu, Jifu
    Shi, Hongbo
    Su, Ziting
    Li, Zhe
    Du, Bilian
    Chen, Yiming
    Tan, Yunbo
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] A High PD-L1 Expression in Non-Small Cell Lung Cancer Correlates with Expression of SPOP and CD8 Tumor-Infiltrating Lymphocytes
    Inoue, M.
    Yoshida, J.
    Oka, S.
    Honda, Y.
    Chikaishi, Y.
    Yasuda, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S461 - S461
  • [49] Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to neoadjuvant chemotherapy (NAD-CT) in locally advanced Gastric Cancer (LAGC)
    Martini, M.
    Zurlo, I. V.
    Strippoli, A.
    Cocomazzi, A.
    Tortora, G.
    Bria, E.
    Basso, M.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S15 - S15
  • [50] PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers
    Ying, Le
    Yan, Feng
    Meng, Qiaohong
    Yu, Liang
    Yuan, Xiangliang
    Gantier, Michael P.
    Williams, Bryan R. G.
    Chan, David W.
    Shi, Liyun
    Tu, Yugang
    Ni, Peihua
    Wang, Xuefeng
    Chen, Weisan
    Zang, Xingxing
    Xu, Dakang
    Hu, Yiqun
    ONCOIMMUNOLOGY, 2018, 7 (06):
12345